Sumitovant Biopharma, Sumitomo Pharma, and Myovant Sciences

Sumitovant Biopharma to Acquire all Outstanding Shares of Myovant for $27 Per Share in Cash Combination Provides Expertise and Resources to Address Unmet...

Related Keywords

United States ,China ,Osaka ,Japan ,Tokyo ,Switzerland ,Sumitomo Pharma ,Maya Frutiger ,Hiroshi Nomura ,Sumitovant Biopharma ,Mark Guinan ,David Marek ,Uneek Mehra ,Myrtle Potter ,Sumitomo Mitsui Banking Corporation ,Jp Morgan Securities ,Committee Of Myovant ,Sumitomo Pharma Co Ltd ,York Stock Exchange ,Sumitomo Pharma Group ,Women Health ,Myovant Sciences ,Meagher Flom ,Exchange Commission ,Sullivan Cromwell ,Myovant Sciences Inc ,Corporate Communications ,Goldman Sachs Co ,New York Stock Exchange ,Sumitovant Biopharma Ltd ,Head Of Corporate Communications ,Outstanding Shares ,Provides Expertise ,Address Unmet Patient Needs ,Prostate Cancer ,Unanimously Recommended ,Special Committee ,Independent Directors ,Sumitomo Mitsui Banking ,New York Stock ,Goldman Sachs ,Biopharma Ltd ,Investor Relations ,Nyse Myov ,Nc ,